Drug profile

The FDA adverse-event record for Gonadorelindiacetate Tetrahydrate Injection

43 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Gonadorelindiacetate Tetrahydrate Injection. See the species affected, top reactions, and outcomes below.

43
adverse-event reports
4.7%
death-coded share
Unknown
most-reported species
19
Uncoded sign - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
43
Total Reports
2
Deaths Reported
4.7%
Death Rate

Active Ingredients

Gonadorelindiacetate Tetrahydrate Injection

Administration Routes

UnknownOtherIntramuscularSubcutaneousTopical

Species Affected

Unknown 34
Human 4
Cattle 4
Dog 1

Most Affected Breeds

Unknown 38
Holstein-Friesian also known as Holstein 2
Shepherd Dog - Belgian Tervueren 1
Aberdeen Angus 1
Jersey 1

Most Reported Reactions

Uncoded sign 19
Physical label missing 7
Missing Labels 5
Vials, Damaged 5
Containers, Damaged 4
Underfilling, Container 4
Accidental exposure 3
Vials, Leaking 3
Physical label loose 2
Death 2
Underfilling, Bottles 1
Caps, Abnormal 1

Outcome Breakdown

Outcome Unknown
6 (66.7%)
Died
2 (22.2%)
Recovered/Normal
1 (11.1%)

Gonadorelindiacetate Tetrahydrate Injection Adverse Event Insights

43 reports name Gonadorelindiacetate Tetrahydrate Injection; 2 recorded a death outcome (4.7% of reported events, not a population-level mortality rate). Active ingredient: Gonadorelindiacetate Tetrahydrate Injection. Administration routes: Unknown, Other, Intramuscular, Subcutaneous.

By species: Unknown (34 reports), Human (4 reports), Cattle (4 reports). By breed: Unknown (38), Holstein-Friesian also known as Holstein (2), Shepherd Dog - Belgian Tervueren (1).

Leading clinical signs: Uncoded sign (19), Physical label missing (7), Missing Labels (5), Vials, Damaged (5). Outcome, 9 coded reports: Outcome Unknown leads at 66.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.